Latest News

Readers hoping to buy Scandinavian Tobacco Group A/S ( CPH:STG ) for its dividend will need to make their move shortly...

In late March 2026, Millrose Properties, Inc. filed an omnibus shelf registration that covers Class A common stock, preferred stock, debt securities, depositary shares, warrants and units, giving it broad flexibility to raise capital as needed. This universal shelf registration broadens Millrose’s financing toolkit, which could influence how it funds future land banking transactions and capital-intensive growth initiatives. We’ll now examine how this expanded flexibility to issue multiple...

Why PHINIA Stock Is Back on Investors’ Radar PHINIA (PHIN) is drawing fresh attention after reporting 2025 results that included a 33% total shareholder return and share repurchases exceeding 20% of outstanding stock since its July 2023 spin off. See our latest analysis for PHINIA. PHINIA’s recent 1 month share price return of 15.85% and 7 day gain of 6.41% suggest momentum has picked up again, even after a 1 day share price decline of 1.36%. The 1 year total shareholder return of 93.73%...

Evercore (EVR) has been in focus after a more than 5.5% intraday rally tied to its work on Danaher, renewed analyst optimism, and growing attention on its upcoming Q1 2026 earnings report. See our latest analysis for Evercore. The recent 1 month share price return of 25.97% and 7 day gain of 10.81% suggest short term momentum has picked up. At the same time, a 90 day share price return of 8.84% and year to date return of 3.81% decline contrast with a 1 year total shareholder return of 96.63%,...

In recent months, IQVIA has rolled out its IQVIA.ai platform in partnership with NVIDIA, acquired drug discovery assets from Charles River Laboratories, and expanded research collaboration with the Duke Clinical Research Institute, while also being ranked the top company on the 2026 Fortune World’s Most Admired Companies List for the fifth consecutive year. Together, these AI-focused initiatives and partnerships underline how IQVIA is weaving advanced computing into regulated life sciences...

In recent days, McKesson has drawn attention as multiple analysts revised their outlooks and the company announced the upcoming retirement of long-time CFO Britt Vitalone, with Kenny Cheung set to assume the role in May 2026. This combination of shifting views on its earnings drivers and a leadership transition in the finance seat has sharpened investor focus on how resilient McKesson’s business model really is. Against this backdrop of analyst reassessments and a CFO transition, we’ll...

In early 2026, Trip.com Group disclosed that Chinese regulators had launched an antitrust investigation into its alleged monopolistic practices and AI-based hotel pricing tool, prompting multiple US securities class action lawsuits claiming the company downplayed regulatory risks. The decision to shut down the automated AI pricing system to address regulators’ concerns also raises questions about how Trip.com balances technology-driven efficiency with fair competition and partner...

GQG Partners (ASX:GQG) has drawn attention after its Emerging Markets Equity Fund sold nearly 1.29 crore shares of ITC Hotels, trimming its stake from 1.97% to 1.35% through an open market transaction. See our latest analysis for GQG Partners. At a latest share price of A$1.78, GQG Partners has delivered a 3 year total shareholder return of 65.61%, even as its year to date share price return of 1.14% suggests momentum has cooled in the short term. If GQG’s portfolio moves have you thinking...

In February 2026, Danaos Corporation reported earnings per share of 7.14 and revenue of US$266.26 million, both ahead of analyst expectations. The twin surprises in profit and sales highlight how Danaos’s containership fleet is currently converting charter demand into stronger-than-forecast financial results. With this earnings beat as a backdrop, we’ll now examine how stronger-than-expected profitability reshapes Danaos’s existing investment narrative. AI is about to change healthcare...

It's been a good week for Shield Therapeutics plc ( LON:STX ) shareholders, because the company has just released its...

The full-year results for Computacenter plc ( LON:CCC ) were released last week, making it a good time to revisit its...

Even if it's not a huge purchase, we think it was good to see that John Wilson, a Checkit plc ( LON:CKT ) insider...

Readers hoping to buy Kendrion N.V. ( AMS:KENDR ) for its dividend will need to make their move shortly, as the stock...

OVH Groupe S.A. ( EPA:OVH ) shareholders are probably feeling a little disappointed, since its shares fell 5.4% to...

In recent days, Tower Semiconductor reported solid sales growth and profits, including sequential and year-over-year revenue increases that have coincided with heavy institutional inflows. This wave of Big Money interest suggests growing confidence in Tower’s fundamentals and its position in higher-value specialty semiconductor niches. Next, we’ll examine how this institutional demand and improving financial performance could influence Tower Semiconductor’s existing investment narrative...

Investors may be wondering whether Capri Holdings shares still offer value after a turbulent few years, or if most of the opportunity is already reflected in the current price. The stock last closed at US$19.88, with returns of 10.7% over 7 days, 7.0% over 30 days, an 18.5% decline year to date and a 35.7% gain over the past year, while 3 and 5 year returns stand at 55.3% and 63.1% declines respectively. Recent price moves have come as investors reassess the brand portfolio and the broader...

Curtiss-Wright recently reported that over the past two years it has delivered 10.9% annual revenue growth, a 16.9% operating margin, and 18.8% annual earnings per share growth, reflecting efficient operations and the impact of share buybacks. At the same time, analysts have raised their earnings estimates and assigned Curtiss-Wright a strong growth-focused rating, suggesting that its operational efficiency and capital returns are increasingly central to how the business is being...

Equinox Gold reported strong Q1 2026 operational results, highlighting solid performance across its mines. The company accelerated expansion of its Canadian operations, reinforcing the importance of these assets after exiting Brazil. Following the divestment of its Brazilian portfolio, Equinox Gold repaid CA$990 million in debt and strengthened its balance sheet. The company introduced its inaugural dividend, signaling a new phase of direct shareholder returns. For investors tracking...

If you are wondering whether Planet Labs PBC is priced attractively or already running ahead of itself, this breakdown will help you assess what the current share price might be implying. The stock recently closed at US$34.67, with returns of 39.9% over 30 days and 69.9% year to date. The 1 year gain is very large and the 3 year return is about 7x. Recent attention on Planet Labs PBC has focused on its role in Earth observation and satellite analytics, as investors consider how its data...

Neogen has agreed to sell its Genomics business to Zoetis as part of a wider portfolio reshaping. The company has completed the divestiture of its Cleaners and Disinfectants business. Neogen is implementing a major restructuring, including a 10% global headcount reduction. These actions concentrate the business around its core Food Safety segment and streamline operations. For investors watching NasdaqGS:NEOG, these moves come after a mixed share price history. The stock is at $9.42, with a...

Valmont Industries recently appointed long-time executive John L. Schwietz as executive vice president, chief financial officer and corporate secretary, while also naming KPMG LLP as its new independent auditor, adding director Paul T. Maass, and increasing its quarterly dividend by 13% to US$0.77 per share. This combination of internal leadership succession, external board and audit refresh, and a higher cash return to shareholders signals an effort to reinforce financial oversight and...

If you are wondering whether Jazz Pharmaceuticals at around US$194.20 is still offering value after a strong run, the key is to look closely at what the current price actually reflects. The stock has posted returns of 3.9% over the last 7 days, 8.8% over 30 days, 12.2% year to date, and 93.2% over the past year, which naturally raises questions about how much of the story is already priced in and how risk is being perceived. Recent attention on Jazz Pharmaceuticals has centered on its...

Conference spotlight and why Innodata is on investor radars Innodata (INOD) is drawing extra attention ahead of its April 7 appearance at Maxim Group’s “Powering the AI Revolution” Virtual Conference, where management is expected to discuss its AI data engineering offerings. See our latest analysis for Innodata. The share price has pulled back recently, with a 7 day share price return of 7.5% and a 30 day share price return of 16.3%. The 1 year total shareholder return of 4.1% contrasts...

Sonic Healthcare recently came under pressure as sector-wide headwinds, including currency shifts, US tariffs, and rising labour costs, weighed on sentiment toward ASX-listed healthcare providers. This sector-driven weakness has put a spotlight on how Sonic’s globally diversified diagnostics operations and existing cost-efficiency efforts might respond to a tougher operating backdrop. We’ll now examine how these sector-wide cost and currency pressures could reshape Sonic Healthcare’s...